Roche Holding AG (OTCMKTS:RHHBY) Position Raised by Bard Financial Services Inc.

Bard Financial Services Inc. raised its stake in Roche Holding AG (OTCMKTS:RHHBY) by 156.8% during the third quarter, according to its most recent disclosure with the SEC. The fund owned 80,500 shares of the company’s stock after buying an additional 49,150 shares during the quarter. Bard Financial Services Inc.’s holdings in Roche were worth $3,216,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in RHHBY. Brooklyn Investment Group acquired a new position in shares of Roche during the third quarter valued at $40,000. AlphaMark Advisors LLC acquired a new position in shares of Roche during the third quarter valued at $149,000. Archer Investment Corp increased its holdings in shares of Roche by 10.6% during the second quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock valued at $236,000 after purchasing an additional 652 shares during the period. IHT Wealth Management LLC acquired a new position in Roche during the third quarter worth about $236,000. Finally, Verity Asset Management Inc. acquired a new position in Roche during the third quarter worth about $253,000.

Roche Stock Performance

RHHBY opened at $35.64 on Wednesday. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43. The stock’s 50 day simple moving average is $37.79 and its 200-day simple moving average is $37.69.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on RHHBY. Deutsche Bank Aktiengesellschaft cut Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Bank of America raised Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, Roche presently has a consensus rating of “Hold”.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.